As the global healthcare space is seeing a palpable shift toward a 'value-based care' model, postoperative pain management is gaining its very own eminence.
This report contains market size and forecasts of Postoperative Pain Therapeutics in global, including the following market information:
- Global Postoperative Pain Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)
- Global Postoperative Pain Therapeutics Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Postoperative Pain Therapeutics companies in 2021 (%)
The global Postoperative Pain Therapeutics market was valued at 10150 million in 2021 and is projected to reach US$ 12060 million by 2028, at a CAGR of 2.5% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Oral Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Postoperative Pain Therapeutics include Mallinckrodt Pharmaceuticals, Pacira BioSciences, Trevena, Heron Therapeutics, Pfizer, Teva Pharmaceutical Industries, Novartis, Camarus and Eli Lilly and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Postoperative Pain Therapeutics manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Postoperative Pain Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Postoperative Pain Therapeutics Market Segment Percentages, by Type, 2021 (%)
- Oral
- Intramuscular
- Intravenous
- Others
Global Postoperative Pain Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Postoperative Pain Therapeutics Market Segment Percentages, by Application, 2021 (%)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Others
Global Postoperative Pain Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Postoperative Pain Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Postoperative Pain Therapeutics revenues in global market, 2017-2022 (Estimated), ($ millions)
- Key companies Postoperative Pain Therapeutics revenues share in global market, 2021 (%)
- Key companies Postoperative Pain Therapeutics sales in global market, 2017-2022 (Estimated), (K Units)
- Key companies Postoperative Pain Therapeutics sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Mallinckrodt Pharmaceuticals
- Pacira BioSciences
- Trevena
- Heron Therapeutics
- Pfizer
- Teva Pharmaceutical Industries
- Novartis
- Camarus
- Eli Lilly
- Bayer AG
